Swiss Life Sciences Stock News

Investors may be asking whether Swisscom at CHF676.0 is offering fair value right now, or if the recent momentum has already priced in the opportunity. The stock has returned 1.0% over the past week, 3.9% over the past month, 16.8% year to date, and 27.2% over the last year, which naturally raises questions about how much of its potential is already reflected in the price. Recent attention on Swisscom has focused on its role as a major Swiss telecom operator and how investors view its...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Partners...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Q1 earnings spark fresh look at Adecco Group stock Adecco Group (SWX:ADEN) just released Q1 2026 results, with organic revenue growth, higher net income and EBITA, and market share gains in the Americas and APAC putting the stock back in focus. See our latest analysis for Adecco Group. Despite the Q1 2026 earnings lift, the share price has fallen 36.36% year to date, contributing to a 33.17% decline in 1 year total shareholder return and signalling fading momentum despite improving...

In early May 2026, Novartis broke ground on a new 46,000 sq. ft radioligand therapy manufacturing facility in Denton, Texas, part of its US$23.00 billion US manufacturing and research expansion and its fifth radioligand therapy site nationwide. This build-out of a coast-to-coast radioligand therapy network highlights how Novartis is tying manufacturing proximity and reliability directly to complex cancer treatment delivery for US patients. We will now explore how this expanded US radioligand...

Landis+Gyr Group (SWX:LAND) has recently drawn attention after its latest financial data showed annual revenue of $1,625.8m and a net loss of $136.1m, prompting investors to reassess the smart metering specialist. See our latest analysis for Landis+Gyr Group. At a share price of CHF47.85, Landis+Gyr Group has seen short term share price momentum pick up, with a 7 day share price return of 6.93%. However, longer term total shareholder returns over 3 and 5 years remain weak and suggest...

Temenos (SWX:TEMN) is back in focus after a cluster of fresh contracts and product launches, including new core banking deals with Habib Bank Limited and Reliance Bank, as well as extended collaborations with First Abu Dhabi Bank and Questrade Financial Group. See our latest analysis for Temenos. The recent stream of banking deals and AI product launches comes against a mixed backdrop. The share price stands at CHF71.45, with a 90 day share price return of 11.29%, but a year to date share...

ABB (SWX:ABBN) has launched what it describes as the world's first IE6 Hyper-Efficiency motor for hazardous areas. The new motor uses rare earth and magnet free SynRM technology and is certified for use in hazardous environments. The product has received both ATEX and IECEx certifications, targeting sectors such as chemicals, oil & gas, and food manufacturing. ABB operates across electrification and automation, supplying equipment and systems that support industrial customers and critical...

Adecco Group (SWX:ADEN) opened 2026 with Q1 revenue of €5.7b and basic EPS of €0.41, setting a clear benchmark for how the year is starting after a steady run of quarterly results. The company has seen revenue move from €5.6b in Q1 2025 to €5.7b in Q1 2026, while basic EPS over that same period went from €0.36 to €0.41. Trailing twelve month EPS of €1.81 provides a broader earnings backdrop. With net income of €69m in the quarter and a net profit margin of 1.3%, the story now is how...

Villars Holding S.A. ( VTX:VILN ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is usually set...

Sunrise Communications (SWX:SUNN) opened 2026 with Q1 revenue of CHF 722.8 million and a loss per share of CHF 0.55, as net income excluding extra items came in at a loss of CHF 40.3 million. Over the past year, revenue has moved in a relatively tight range between CHF 722.1 million and CHF 788.8 million per quarter, while quarterly EPS has fluctuated between a loss of CHF 0.02 and a loss of CHF 2.00. This puts the latest trailing twelve-month EPS at a loss of CHF 2.08. For investors, the key...

Highlight Event and Entertainment (SWX:HLEE) has posted its FY 2025 results, reporting first half revenue of CHF194.9 million and a loss per share of CHF1.20. On a trailing twelve month basis, revenue stands at CHF544.4 million with a loss per share of CHF10.65, reflecting ongoing profitability pressures. Over recent periods, revenue has moved between CHF235.5 million and CHF310.3 million per half year, while basic EPS has ranged from a loss of CHF0.85 to a loss of CHF1.20. This highlights...

Züblin Immobilien Holding (SWX:ZUBN) has reported its FY 2026 results with first half revenue of CHF 4.95 million and basic EPS of CHF 1.31, while trailing 12 month figures show revenue of CHF 9.84 million and basic EPS of CHF 2.27, both shaped by a CHF 3.1 million one off gain in the period. Over recent periods, revenue has moved from CHF 4.37 million in the first half of FY 2025 to CHF 4.80 million in the second half and then CHF 4.95 million in the first half of FY 2026. EPS shifted from...

Akkodis, a subsidiary of Adecco Group (SWX:ADEN), has been recognized as an Enterprise Innovator for its agentic AI capabilities. The recognition highlights Akkodis' progress in practical AI deployment and Services-as-Software transformation across enterprise clients. The assessment emphasizes strengths in scalable AI execution and data governance, pointing to operational impact beyond financial metrics. Adecco Group, through Akkodis, is leaning into AI driven services at a time when large...

Valiant Holding AG ( VTX:VATN ) is about to trade ex-dividend in the next three days. Typically, the ex-dividend date...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Roche Holding received CE Mark approval for its Elecsys pTau217 blood test for Alzheimer's disease in Europe. The assay is designed to detect amyloid pathology through a minimally invasive blood draw, supporting faster assessment in primary and secondary care. The approval adds to Roche's diagnostics portfolio in neurodegenerative disease and may influence how clinicians approach early Alzheimer's evaluation. For investors tracking SWX:ROP, the CE Mark arrives with the stock trading at...

Swisscom shares in focus after recent price move Swisscom (SWX:SCMN) has come into focus for investors after a recent share price move, with the stock last closing at CHF 678. This has drawn attention to its recent performance and valuation signals. See our latest analysis for Swisscom. Beyond the latest move to CHF 678, Swisscom’s recent momentum has been relatively steady, with a 30 day share price return of 2.57%, while the 1 year total shareholder return of 31.29% highlights the longer...

Recent performance snapshot UBS Group (SWX:UBSG) has drawn investor attention after a recent move in the share price, with the stock last closing at CHF 36.22. That puts its market value around CHF 106b. Over the past month, the stock has returned 9.6%, and over the past 3 months it has returned 12.4%. The 1 year total return stands at 35.0%, with a 3 year total return a little over 12x and a 5 year total return almost 20x. See our latest analysis for UBS Group. The recent 1 day share price...

The new CreativeX and CreatorIQ integration, developed with Nestlé (SWX:NESN), puts the company’s creator marketing under a single system. It automates content scoring and approval before paid media budgets are deployed worldwide. See our latest analysis for Nestlé. Despite the CreativeX and CreatorIQ integration highlighting Nestlé’s push to tighten its marketing workflows, the CHF77.32 share price sits against a mixed backdrop, with modest year to date share price gains but weaker multi...

PSP Swiss Property (SWX:PSPN) has opened Q1 2026 earnings season with trailing 12 month revenue of CHF 351.05 million and Basic EPS of CHF 8.91, backed by an 8.9% year over year improvement in earnings and supported by a one off gain of CHF 238.8 million that lifted reported profit. Over recent quarters, revenue has held in a tight band between CHF 87.44 million and CHF 88.65 million per quarter, while quarterly Basic EPS has ranged from CHF 1.32 to CHF 3.25. This has fed into that CHF 8.91...

The European market has experienced a week of volatility, with the pan-European STOXX Europe 600 Index achieving modest gains amidst easing geopolitical tensions and strong corporate earnings. However, potential tariff threats from the U.S. have introduced uncertainties that could impact future performance. In such an environment, stocks with high insider ownership can be appealing as they often indicate confidence in the company's growth prospects and alignment of interests between...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Q1 earnings set the tone for Swiss Re stock Swiss Re (SWX:SREN) put its first quarter on the table on May 7, reporting net income of US$1,506 million versus US$1,267 million a year earlier, alongside its Q1 2026 earnings call. See our latest analysis for Swiss Re. Despite the stronger Q1 net income, the stock has come under pressure, with the share price down 10.6% over the past month and the 1 year total shareholder return declining 14.08%, although the 5 year total shareholder return of...